Chris Nolet - Oct 12, 2022 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
Director
Signature
By: /s/ Jeet Mahal, as Attorney-in-Fact
Stock symbol
JSPR
Transactions as of
Oct 12, 2022
Transactions value $
$0
Form type
4
Date filed
10/13/2022, 08:00 PM
Previous filing
Oct 4, 2022
Next filing
Jan 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JSPR Voting Common Stock Award $0 +32.5K $0.00 32.5K Oct 12, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are represented by restricted stock units, 1/2 of which shall vest on each of April 12, 2023 and October 12, 2023, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.